Veronica Jové
Associate Director, Asset Team Lead @ Recursion
- Role
- Translational Medicine Senior Scientist at SpringWorks Therapeutics
- Location
- New York, NY, US
- LinkedIn followers
- 500 followers
About Veronica Jové
Creative PhD scientist with expertise in External Innovation and Translational Medicine> Distilled high-dimensional data to position translatability, differentiation, and portfolio impact for precision medicines at Pfizer and SpringWorks Therapeutics > Led Translational Medicine strategy and matrixed teams to inform Global Program strategy and advance assets across the development life cycle:Discovery > IND-enabling > Phase 1/FIH (SW-682, brimarafenib)> Commercial Launch/LCM (OGSIVEO)> Performed scientific due diligence for inbound opportunities, novel targets, and external partnerships, delivering data-driven recommendations to leadership> Accomplished publication record in high impact journals, including Science, Neuron, and Nature Immunology> Recipient of the Pfizer UpJohn Award, SpringWorks Therapeutics Award in R&D, Howard Hughes Medical Institute Gilliam Fellowship, National Science Foundation Graduate Research Fellowship, and David Rockefeller Award to recognize the PhD student who shows exceptional promise at Rockefeller University
Experience
Translational Medicine Senior Scientist
Feb 2024 — Present · New York, NY, US
Program co-leader and Clinical biomarker leader• Managed efficacy and biomarker studies to support regulatory submissions and clinical protocol development• Prioritized new indications and rational combinations for OGSIVEO, TEAD inhibitors (Phase 1a), and an undisclosed target (IND-enabling) by integrating multi-omics datasets with preclinical data and clinical outcomes• As a Program Co-lead, spearheaded a new portfolio program by leading successful New Target Proposals and integrating target biology insights with unmet medical need, feasibility, portfolio fit, and competitive landscape.• Clinical Biomarker Lead for NCT06••••77 (Phase 1) brimarafenib with panitumumab in participants with advanced or metastatic RAS mutant colorectal and pancreatic ductal cancer • Identified predictive biomarkers to guide patient selection by supervising efficacy and bioinformatics studies in a mouse clinical trial across 25 in vivo models (Chen, L, Jové, V, et al, EOTRC-NCI-AACR poster, 2024)• Translational Medicine representative for SpringWorks’ Regulatory Intelligence Committee
Education
Columbia University
Bachelor's degree, Biological Sciences and Hispanic Studies
2010 — 2014
The Rockefeller University
Doctor of Philosophy - PhD, Neuroscience and Genetics
2014 — 2020
Marine Biology Laboratory
Neurobiology Course
2015 — 2015
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.